Main Facts and Executive Summary The intersection of weight management and sleep medicine has entered a transformative era. Glucagon-like peptide-1 receptor agonists (GLP-1s)—such as semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (marketed as Zepbound)—have emerged as powerful therapeutic tools not only for type 2 diabetes and chronic weight management, but increasingly for obstructive sleep … Read More “Navigating Insurance Coverage for GLP-1 Weight Loss Drugs in Obstructive Sleep Apnea Treatment” »
Tag: obstructive
Main Facts The landscape of treating obstructive sleep apnea (OSA) is undergoing a significant transformation. Historically managed primarily through lifestyle interventions, continuous positive airway pressure (CPAP) therapy, and surgical options, physicians and patients are increasingly turning to a new pharmacological frontier: glucagon-like peptide-1 receptor agonists (GLP-1s). Popularized by medications like Ozempic, Wegovy, and Zepbound, these … Read More “Navigating Insurance Coverage for GLP-1 Medications in the Treatment of Obstructive Sleep Apnea” »
For millions of adults worldwide, a restful night’s sleep is an elusive luxury. Obstructive sleep apnea (OSA)—a condition characterized by repeated airway collapses that interrupt breathing—has long been managed primarily through mechanical interventions like Continuous Positive Airway Pressure (CPAP) machines. However, a new frontier in metabolic health is emerging as a potential game-changer: Glucagon-like peptide-1 … Read More “The Weight of Sleep: Understanding the Role of GLP-1s in Treating Obstructive Sleep Apnea” »
